Harmut Porst

Learn More
Vardenafil, a novel selective phosphodiesterase type 5 inhibitor, was evaluated in its first large-scale at-home trial. A total of 601 men with mild to severe erectile dysfunction (ED) were enrolled(More)
Long-term efficacy and safety of Alprostadil-Alfadex (EDEXR/VIRIDALR) in intracavernous self-injection therapy for chronical erectile failure was investigated in a four year running multicenter(More)